Inflammatory Rheumatic Diseases
Nearly 70% of patients with inflammatory rheumatic disease miss physical activity targets
More than two-thirds patients with inflammatory rheumatic diseases fall short of physical activity targets for moderate-to-vigorous exercise, according to data published in Rheumatology Advances in Practice.
EULAR: Physical activity, regular assessment recommended for fatigue in inflammatory RMD
Fatigue in patients with inflammatory rheumatic and musculoskeletal diseases should be addressed with tailored physical activity, psychoeducational interventions or possibly immunomodulatory treatment, according to EULAR recommendations.
Longer interval between COVID-19 vaccine doses increases antibody levels in IRD patients
SAN DIEGO — A longer interval between the second and third SARS-CoV-2 vaccine doses results in greater antibody response in patients with inflammatory rheumatic diseases, according to data presented at ACR Convergence 2023.
Half of long COVID patients form ‘inflammatory subset,’ may benefit from immunomodulation
Half of patients with long COVID demonstrate persistent inflammation and may potentially benefit from immunomodulation, according to data.
Patients with inflammatory rheumatic disease at higher risk for severe COVID-19
Patients with inflammatory rheumatic diseases are as likely as the general population to contract COVID-19, but are at a higher risk for severe outcomes, including hospitalization and death, according to data.
COVID-19 pandemic impacted physical, mental health of 40% of rheumatic disease patients
Approximately 40% of patients with inflammatory rheumatic disease report adverse physical and mental impacts stemming from the COVID-19 pandemic, according to data published in Clinical Rheumatology.